Literature DB >> 15121323

A global perspective on vaccine safety.

Philippe Duclos1.   

Abstract

"Immunization Safety" (i.e., ensuring and monitoring the safety of all aspects of immunization, including vaccine quality, storage and handling, vaccine administration and the disposal of sharps) remains a major challenge. Any vaccine safety issue, real or perceived, may lead to rumors and undermine confidence in vaccination and, ultimately, have dramatic consequences for immunization coverage and disease incidence. In 1999, WHO's Department of Vaccines and Biologicals launched the Immunization Safety Priority Project to establish a comprehensive system to ensure the safety of all immunizations given in national immunization programmes. The project aims at strengthening each country's capacity. The principal areas of activity of the project include: research and development of safer vaccines and safer and simpler vaccine delivery technologies; assurance of vaccine safety through quality control procedures and quality specifications; implementation of tools to ensure vaccine quality up to vaccine administration; access to safe and efficient vaccine administration technologies and their disposal; and identification and management of risks related to immunization. This report focuses on the latter area and highlights challenges and critical factors in establishing a safety profile for a vaccine and the importance and limits of post market surveillance. It presents some of WHO's supporting activities among which the establishment of a Global Advisory Committee on Vaccine Safety to provide an independent scientific assessment of vaccine safety issues. WHO has a role to play not only because of its technical and normative role but also because of its privileged relation with country authorities and its global vision and mandate and being perceived as neutral and free of conflicts of interest.

Mesh:

Substances:

Year:  2004        PMID: 15121323     DOI: 10.1016/j.vaccine.2004.01.010

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  8 in total

1.  Evaluation of 'SAEFVIC', A Pharmacovigilance Surveillance Scheme for the Spontaneous Reporting of Adverse Events Following Immunisation in Victoria, Australia.

Authors:  Hazel J Clothier; Nigel W Crawford; Melissa Russell; Heath Kelly; Jim P Buttery
Journal:  Drug Saf       Date:  2017-06       Impact factor: 5.606

2.  Enhancing the work of the Department of Health and Human Services national vaccine program in global immunization: recommendations of the National Vaccine Advisory Committee: approved by the National Vaccine Advisory Committee on September 12, 2013.

Authors: 
Journal:  Public Health Rep       Date:  2014       Impact factor: 2.792

Review 3.  Contributions and challenges for worldwide vaccine safety: The Global Advisory Committee on Vaccine Safety at 15 years.

Authors:  Edwin J Asturias; Melinda Wharton; Robert Pless; Noni E MacDonald; Robert T Chen; Nicholas Andrews; David Salisbury; Alexander N Dodoo; Kenneth Hartigan-Go; Patrick L F Zuber
Journal:  Vaccine       Date:  2016-05-16       Impact factor: 3.641

4.  A prospective cohort study comparing the reactogenicity of trivalent influenza vaccine in pregnant and non-pregnant women.

Authors:  Annette K Regan; Lauren Tracey; Christopher C Blyth; Donna B Mak; Peter C Richmond; Geoffrey Shellam; Caroline Talbot; Paul V Effler
Journal:  BMC Pregnancy Childbirth       Date:  2015-03-18       Impact factor: 3.007

5.  Vaccine confidence in China after the Changsheng vaccine incident: a cross-sectional study.

Authors:  Baohua Liu; Ruohui Chen; Miaomiao Zhao; Xin Zhang; Jiahui Wang; Lijun Gao; Jiao Xu; Qunhong Wu; Ning Ning
Journal:  BMC Public Health       Date:  2019-11-27       Impact factor: 3.295

Review 6.  SARS-CoV-2 vaccines: A critical perspective through efficacy data and barriers to herd immunity.

Authors:  Francesco Blasi; Andrea Gramegna; Giovanni Sotgiu; Laura Saderi; Antonio Voza; Stefano Aliberti; Francesco Amati
Journal:  Respir Med       Date:  2021-03-06       Impact factor: 4.582

7.  Is vaccine hesitancy justified? Benchmarking post-market vaccine risks with five commonly used medicinal products in Canada.

Authors:  Tuhin Maity; Ahmad von Schlegell; Christopher Longo
Journal:  Can J Public Health       Date:  2022-02-11

Review 8.  The safety of vaccines.

Authors:  Derek T O'Hagan; Rino Rappuoli
Journal:  Drug Discov Today       Date:  2004-10-01       Impact factor: 7.851

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.